← Eichor
Condition: Copeptin Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Copeptin

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Vasopressin and Pain Perception in the Brain
Phase 1/Phase 2 · 1 location(s) · University of Maryland, Baltimore · NCT03446456
Copeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of Polyuria-polydipsia Syndrome
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT07569861
HYdrocortisone and VAsopressin in Post-RESuscitation Syndrome
Phase 3 · 14 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04591990
The Effect of Prehospital Combination of Epinephrine, Vasopressin, and Steroid in OHCA
NA · 1 location(s) · National Taiwan University Hospital · NCT06203847
Efficacy of Early Argipressin in the Management of Intensive Care Patients With Norepinephrine-refractory Vasoplegic Sho
Phase 3 · 1 location(s) · Centre Hospitalier Universitaire Dijon · NCT07063680
Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency
Phase 1 · 1 location(s) · Elizabeth Austen Lawson · NCT04789148
Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-Deficiency
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT07361263
Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease
EARLY_Phase 1 · 1 location(s) · Massachusetts General Hospital · NCT07568509
Early Versus Late Adjunctive Vasopressin in Septic Shock
Phase 4 · 1 location(s) · The Cleveland Clinic · NCT06709573
Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Control
Phase 2 · 1 location(s) · University Hospital, Basel, Switzerland · NCT06808516
Copeptin and Thirst: Possible Predictive Markers of Effectiveness of Bariatric Surgery?
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06806787
Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress Syndrome
Phase N/A · 1 location(s) · Tanta University · NCT07154134
Efficacy of a Smart Water Bottle Intervention to Increase Fluid Consumption in College Students
NA · 1 location(s) · Kennesaw State University · NCT06259799
The Trend of Copeptin Levels and Its Clinical Value for Postoperative CDI in Pediatric Patients After NSI in ICU
Phase N/A · 1 location(s) · Children's Hospital of Fudan University · NCT06742060
VAsopressin and STeroids in Addition to Adrenaline in Cardiac Arrest - a Randomized Clinical Trial
Phase 3 · 2 location(s) · Tiohundra AB · NCT05139849
Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication
Phase N/A · 12 location(s) · Jamil Cedeño Mora · NCT07255378
Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation (AVENIR
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06344442
Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus
Phase 2 · 3 location(s) · University Hospital, Basel, Switzerland · NCT06036004
Plasma Oxytocin Changes in Response to Music Modified by Sonic Augmentation Technology
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT07276152
Monogenic Diabetes Misdiagnosed as Type 1
Phase N/A · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT03988764
Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patient
Phase 2 · 1 location(s) · University Hospital, Basel, Switzerland · NCT06676774
Vasoactive Drugs in Intensive Care Unit
Phase 4 · 1 location(s) · University of Chicago · NCT02118467
National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852
Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate Antidiuresis
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT06821802
Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and He
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT06789705
Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT02841553
Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis
Phase 3 · 8 location(s) · Hospital do Coracao · NCT06464510
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · 114 location(s) · Children's Oncology Group · NCT06368817
Effects of Ephedrine, Phenylephrine, Norepinephrine and Vasopressin on Contractility of Human Myometrium and Umbilical V
NA · 1 location(s) · Samuel Lunenfeld Research Institute, Mount Sinai Hospital · NCT04053478
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
Phase 2 · 15 location(s) · Jason Sperry · NCT05958342
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.